Trypanosoma Brucei Brucei: the Response to Melarsoprol in Mice with Cerebral Trypanosomiasis. An Immunopathological Study

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1981 Nov 1

PMID 7039886

Citations 3

Authors

A A Poltera

A HOCHMANN

P H Lambert

Affiliations

Soon will be listed here.

Abstract

A murine model for cerebral trypanosomiasis was adapted to study the efficacy of Melarsoprol which was apparently curative in high intravenous doses (10 mg/kg, 3 x 10 mg/kg, 20 mg/kg) in advanced infection (6th week); only one relapse occurred, but observation time was limited. Deposits of Ig and C3 in the choroid plexuses tended to disappear after successful treatment. Circulating immune complexes increased in the 1st week after therapy and returned to normal values in the 2nd week. Such an increase could temporarily be prevented by chloroquine, which may explain the reported reduction of side-effects from Melarsoprol in man after use of chloroquine in sleeping sickness. Melarsoprol (3 x 3.6 mg/kg) given intraperitoneally showed apparent cures but also relapses. Melarsoprol in high intraperitoneal doses (3 x 10 mg/kg) showed an increasing number of relapses if related to the duration of infection. Morphologically, a diffuse interstitial distribution of the parasites appeared in the CNS after relapse had occurred (shift), contrasting with the preferential localization of the parasites in the choroid plexuses of untreated mice. Such a shift was best visualized by immunofluorescence using specific antitrypanosomal antibodies. Relapse-mice invariably showed increased levels of circulating immune complexes suggesting this serological test for early detection of relapses. Tissue parasites appeared to be a likely cause of relapses, irrespective of the duration of infection. A short observation time with no circulating blood parasites is no guarantee of cure. Benznidazole (3 x 1 g/kg) was ineffective in advanced infection.

Citing Articles

Delineating neuroinflammation, parasite CNS invasion, and blood-brain barrier dysfunction in an experimental murine model of human African trypanosomiasis.

Rodgers J, Bradley B, Kennedy P Methods. 2017; 127:79-87.

PMID: 28636879 PMC: 5595161. DOI: 10.1016/j.ymeth.2017.06.015.

Cardiac alterations in human African trypanosomiasis (T.b. gambiense) with respect to the disease stage and antiparasitic treatment.

Blum J, Schmid C, Burri C, Hatz C, Olson C, Fungula B PLoS Negl Trop Dis. 2009; 3(2):e383.

PMID: 19221604 PMC: 2640099. DOI: 10.1371/journal.pntd.0000383.

Towards developing a diagnostic regimen for the treatment follow-up of Trypanosoma brucei gambiense.

Mbati P, Hirumi K, Inoue N, Situakibanza N, Hirumi H Korean J Parasitol. 2000; 37(4):289-92.

PMID: 10634047 PMC: 2733208. DOI: 10.3347/kjp.1999.37.4.289.

References

MANUELIDIS E, Robertson D, AMBERSON J, Polak M, HAYMAKER W . Trypanosoma rhodesiense encephalitis. Clinicopathological study of five cases of encephalitis and one of mel B hemorrhagic encephalopathy. Acta Neuropathol. 1965; 5(2):176-204. DOI: 10.1007/BF00686517. View

Robertson D . The treatment of sleeping sickness (mainly due to Trypanosoma rhodesiense) with melarsoprol. Trans R Soc Trop Med Hyg. 1963; 57:176-83. DOI: 10.1016/0035-9203(63)90059-2. View

Ormerod W, Venkatesan S . The occult visceral phase of mammalian trypanosomes with special reference to the life cycle of Trypanosoma (Trypanozoon) brucei. Trans R Soc Trop Med Hyg. 1971; 65(6):722-35. DOI: 10.1016/0035-9203(71)90087-3. View

Ogada T, Fink E, Mbwabi D . Clinical trials of diamidine 98-202 in Rhodesian sleeping sickness. Trans R Soc Trop Med Hyg. 1973; 67(2):280-1. DOI: 10.1016/0035-9203(73)90197-1. View

Buyst H . The treatment of T. rhodesiense sleeping sickness, with special reference to its physio-pathological and epidemiological basis. Ann Soc Belg Med Trop. 1975; 55(2):95-104. View

Zubler R, LANGE G, Lambert P, MIESCHER P . Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus. J Immunol. 1976; 116(1):232-5. View

Opperdoes F, Borst P, Fonck K . The potential use of inhibitors of glycerol-3-phosphate oxidase for chemotherapy of African trypanosomiasis. FEBS Lett. 1976; 62(2):169-72. DOI: 10.1016/0014-5793(76)80045-2. View

Raether W, Seidenath H . Trypanocidal effect of diamidine 98/202 in experimental Trypanosoma rhodesiense infection of the stumptailed macaque (Macaca arctoides). Tropenmed Parasitol. 1976; 27(2):238-44. View

Williamson J . Chemotherapy of African trypanosomiasis. Trop Dis Bull. 1976; 73(7):531-42. View

10.

Aiyedun B, Amodu A . Mel B toxicity in human trypanosomiasis in the Gboko endemic area of Nigeria. Acta Trop. 1976; 33(1):96-100. View

11.

GOODWIN L, Tierney E . Trypanocidal activity of blood and tissue fluid from normal and infected rabbits treated with curative drugs. Parasitology. 1977; 74(1):33-45. DOI: 10.1017/s003118200004751x. View

12.

Lowenthal M, JONES I, Kouchner G, Desai M, Chimbayo W, Rajappan C . Nitrofurazone as primary therapy for trypanosomal meningo-encephalitis. Trans R Soc Trop Med Hyg. 1977; 71(1):88-9. DOI: 10.1016/0035-9203(77)90220-6. View

13.

Poltera A, OWOR R, Cox J . Pathological aspects of human African trypanosomiasis (HAT) in Uganda. A post-mortem survey of fourteen cases. Virchows Arch A Pathol Anat Histol. 1977; 373(3):249-65. DOI: 10.1007/BF00432240. View

14.

Stevens D, MOULTON J . Experimental meningoencephalitis in Trypanosoma brucei infection of deer mice (Peromyscus maniculatus). A light, immunofluorescent, and electron microscopic study. Acta Neuropathol. 1977; 38(3):173-80. DOI: 10.1007/BF00688062. View

15.

Evans D, Brightman C, Holland M . Salicylhydroxamic-acid/glycerol in experimental trypanosomiasis. Lancet. 1977; 2(8041):769. DOI: 10.1016/s0140-6736(77)90282-3. View

16.

JENNINGS F, Whitelaw D, URQUHART G . The relationship between duration of infection with Trypanosoma brucei in mice and the efficacy of chemotherapy. Parasitology. 1977; 75(2):143-53. DOI: 10.1017/s0031182000062284. View

17.

Fairlamb A, Bowman I . Trypanosoma brucei: suramin and other trypanocidal compounds' effects on sn-glycerol-3-phosphate oxidase. Exp Parasitol. 1977; 43(2):353-61. DOI: 10.1016/0014-4894(77)90040-6. View

18.

Antoine P . [Neurological and psychological studies of patients with sleeping sickness and their course]. Ann Soc Belg Med Trop. 1977; 57(4-5):227-48. View

19.

Evans D, Holland M . Effective treatment of Trypanosoma vivax infections with salicylhydroxamic acid (SHAM). Trans R Soc Trop Med Hyg. 1978; 72(2):203-4. DOI: 10.1016/0035-9203(78)90065-2. View

20.

Polak A, RICHLE R . Mode of action of the 2-nitroimidazole derivative benznidazole. Ann Trop Med Parasitol. 1978; 72(1):45-54. DOI: 10.1080/00034983.1978.11719278. View